It's been studied since the 1960s, originally found in the thymus gland (hence thymosin)
Consequently, targeting these transporters is a promising approach for tumor treatment
Instead, it works downstream to protect cells from the damage that often results from metabolic activity
Supplementary Material Abbreviations ACN acetonitrile aCSF artificial cerebrospinal fluid AngIV angiotensin IV ANOVA analysis of variance AUC area under the curve BBB blood-brain barrier Cl int average intrinsic clearance C max concentration in plasma extrapolated to time zero (C 0 ) dihexa N -hexanoic-Tyr-Ile-(6) amino-hexanoic amide DMSO dimethyl sulfoxide HGF hepatocyte growth factor HPLC high-pressure liquid chromatography logP log transformation of the octanol/water partition ratio and measure of hydrophilicity mEPSC miniature excitatory postsynaptic currents Nle 1 -AngIV Nle-Tyr-Ile-His-Pro-Phe PBS phosphate-buffered saline P eff predicted effective human jejunal permeability PIPES piperazine- N , N -bis(2-ethanesulfonic acid) t 1/2 terminal elimination rate constant V d volume of distribution VGLUT1 vesicular glutamate transporter 1 Authorship Contributions Participated in research design: McCoy, Benoist, Wright, Harding, Appleyard, Wayman, Kawas
Related resources: glutamate foods and ketone ester therapy This OCD page should connect directly to the deeper diet and metabolic therapy articles
